FDA Pushes For Prescription-Only Sale Of Skin-Bleaching Products
This article was originally published in The Tan Sheet
Executive Summary
FDA is proposing a rule that classifies all over-the-counter skin-bleaching products as drugs requiring an approved new drug application, the agency announced in a notice of proposed rulemaking published in an Aug. 29 Federal Register notice